港股異動 | 敏華控股(1999.HK)連續第4日上漲 績後獲投行扎堆唱好
格隆匯11月16日丨敏華控股(1999.HK)續升5.61%,4日連漲超20%。報13.94港元,總市值551億港元。日前公司公佈,中期股東應占溢利同比增長31.87%至9.88億港元,擬派息每股0.13港元。長江證券點評稱,內外銷均實現高增長,多因素影響利潤率表現,維持“買入”評級;太平洋證券亦維持買入”評級,開店超預期、同店提升驅動內銷延續高增;東吳證券維持其“買入”評級,指業績靚麗符合預期,內銷延續增長。興業證券、德邦證券、西部證券等多數券商均唱好。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.